Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma
Asthma is a chronic respiratory disease affecting people of all ages, especially children, worldwide. Origins of asthma are suggested to be placed in early life with heterogeneous clinical presentation, severity and pathophysiology. Exacerbations of asthma disease can be triggered by many factors, i...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6840a7bd45d44656998eeb421323f7f7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6840a7bd45d44656998eeb421323f7f7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6840a7bd45d44656998eeb421323f7f72021-11-10T06:31:06ZRegulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma1664-322410.3389/fimmu.2021.731807https://doaj.org/article/6840a7bd45d44656998eeb421323f7f72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.731807/fullhttps://doaj.org/toc/1664-3224Asthma is a chronic respiratory disease affecting people of all ages, especially children, worldwide. Origins of asthma are suggested to be placed in early life with heterogeneous clinical presentation, severity and pathophysiology. Exacerbations of asthma disease can be triggered by many factors, including viral respiratory tract infections. Rhinovirus (RV) induced respiratory infections are the predominant cause of the common cold and also play a crucial role in asthma development and exacerbations. Rhinovirus mainly replicates in epithelial cells lining the upper and lower respiratory tract. Type III interferons, also known as interferon-lambda (IFNλ), are potent immune mediators of resolution of infectious diseases but they are known to be involved in autoimmune diseases as well. The protective role of type III IFNs in antiviral, antibacterial, antifungal and antiprotozoal functions is of major importance for our innate immune system. The IFNλ receptor (IFNλR) is expressed in selected types of cells like epithelial cells, thus orchestrating a specific immune response at the site of viruses and bacteria entry into the body. In asthma, IFNλ restricts the development of TH2 cells, which are induced in the airways of asthmatic patients. Several studies described type III IFNs as the predominant type of interferon increased after infection caused by respiratory viruses. It efficiently reduces viral replication, viral spread into the lungs and viral transmission from infected to naive individuals. Several reports showed that bronchial epithelial cells from asthmatic subjects have a deficient response of type III interferon after RV infection ex vivo. Toll like Receptors (TLRs) recognize pathogen-associated molecular patterns (PAMPs) expressed on infectious agents, and induce the development of antiviral and antibacterial immunity. We recently discovered that activation of TLR7/8 resulted in enhanced IFNλ receptor mRNA expression in PBMCs of healthy and asthmatic children, opening new therapeutic frontiers for rhinovirus-induced asthma. This article reviews the recent advances of the literature on the regulated expression of type III Interferons and their receptor in association with rhinovirus infection in asthmatic subjects.Susanne KrammerCristina Sicorschi GutuJanina C. GrundMircea T. ChiriacSabine ZirlikSusetta FinottoFrontiers Media S.A.articleasthmainterferonrhinovirusexacerbationTLR7/8epithelial cellsImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
asthma interferon rhinovirus exacerbation TLR7/8 epithelial cells Immunologic diseases. Allergy RC581-607 |
spellingShingle |
asthma interferon rhinovirus exacerbation TLR7/8 epithelial cells Immunologic diseases. Allergy RC581-607 Susanne Krammer Cristina Sicorschi Gutu Janina C. Grund Mircea T. Chiriac Sabine Zirlik Susetta Finotto Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma |
description |
Asthma is a chronic respiratory disease affecting people of all ages, especially children, worldwide. Origins of asthma are suggested to be placed in early life with heterogeneous clinical presentation, severity and pathophysiology. Exacerbations of asthma disease can be triggered by many factors, including viral respiratory tract infections. Rhinovirus (RV) induced respiratory infections are the predominant cause of the common cold and also play a crucial role in asthma development and exacerbations. Rhinovirus mainly replicates in epithelial cells lining the upper and lower respiratory tract. Type III interferons, also known as interferon-lambda (IFNλ), are potent immune mediators of resolution of infectious diseases but they are known to be involved in autoimmune diseases as well. The protective role of type III IFNs in antiviral, antibacterial, antifungal and antiprotozoal functions is of major importance for our innate immune system. The IFNλ receptor (IFNλR) is expressed in selected types of cells like epithelial cells, thus orchestrating a specific immune response at the site of viruses and bacteria entry into the body. In asthma, IFNλ restricts the development of TH2 cells, which are induced in the airways of asthmatic patients. Several studies described type III IFNs as the predominant type of interferon increased after infection caused by respiratory viruses. It efficiently reduces viral replication, viral spread into the lungs and viral transmission from infected to naive individuals. Several reports showed that bronchial epithelial cells from asthmatic subjects have a deficient response of type III interferon after RV infection ex vivo. Toll like Receptors (TLRs) recognize pathogen-associated molecular patterns (PAMPs) expressed on infectious agents, and induce the development of antiviral and antibacterial immunity. We recently discovered that activation of TLR7/8 resulted in enhanced IFNλ receptor mRNA expression in PBMCs of healthy and asthmatic children, opening new therapeutic frontiers for rhinovirus-induced asthma. This article reviews the recent advances of the literature on the regulated expression of type III Interferons and their receptor in association with rhinovirus infection in asthmatic subjects. |
format |
article |
author |
Susanne Krammer Cristina Sicorschi Gutu Janina C. Grund Mircea T. Chiriac Sabine Zirlik Susetta Finotto |
author_facet |
Susanne Krammer Cristina Sicorschi Gutu Janina C. Grund Mircea T. Chiriac Sabine Zirlik Susetta Finotto |
author_sort |
Susanne Krammer |
title |
Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma |
title_short |
Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma |
title_full |
Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma |
title_fullStr |
Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma |
title_full_unstemmed |
Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma |
title_sort |
regulation and function of interferon-lambda (ifnλ) and its receptor in asthma |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/6840a7bd45d44656998eeb421323f7f7 |
work_keys_str_mv |
AT susannekrammer regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma AT cristinasicorschigutu regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma AT janinacgrund regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma AT mirceatchiriac regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma AT sabinezirlik regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma AT susettafinotto regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma |
_version_ |
1718440474564362240 |